DOES ADHERENCE TO INHALED THERAPY CHANGE FOLLOWING INITIATION OF MEPOLIZUMAB IN THE TREATMENT OF SEVERE ASTHMA?

被引：0
|
作者：
d'Ancona, G. [1 ]
Liu, B. [2 ]
Wei, L. [2 ]
Green, L. [1 ]
Fernandes, M. [1 ]
Roxas, C. [1 ]
Osman, L. [1 ]
Kavanagh, J. [1 ]
Jackson, D. J. [1 ]
Kent, B. D. [1 ]
机构：
[1] Guys Hosp, London, England
[2] UCL Sch Pharm, London, England
来源：
THORAX | 2018年 / 73卷
关键词：
D O I：
10.1136/thorax-2018-212555.87
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
S81
引用
下载
收藏
页码：A50 / A51
页数：2
相关论文
共 50 条
  • [41] Clinical and Immunological Effect of Mepolizumab Treatment in Patients with Severe Asthma
    Sasano, H.
    Harada, N.
    Sandhu, Y.
    Tanabe, Y.
    Harada, S.
    Watanabe, T.
    Sato, Y.
    Nishimaki, T.
    Oyama, Y.
    Abe, S.
    Ueda, S.
    Takeshige, T.
    Matsuno, K.
    Ito, J.
    Takahashi, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [42] BUDGET IMPACT ANALYSIS OF MEPOLIZUMAB AS AN ADD-ON THERAPY IN THE TREATMENT OF SEVERE EOSINOPHILIC ASTHMA IN CHILE
    Abbott, T.
    Balmaceda, C.
    Espinoza, M. A.
    VALUE IN HEALTH, 2020, 23 : S15 - S15
  • [43] THE EFFECT OF MEPOLIZUMAB TREATMENT IN PATIENTS WITH SEVERE ASTHMA IN 1 YEAR
    Sasano, Hitoshi
    Harada, Norihiro
    Takeshige, Tomohito
    Tanabe, Yuki
    Harada, Sonoko
    Sandhu, Yuuki
    Matsuno, Kei
    Ito, Jun
    Akiba, Hisaya
    Takahashi, Kazuhisa
    RESPIROLOGY, 2019, 24 : 197 - 198
  • [44] A nursing protocol for mepolizumab administration in the treatment of eosinophilic severe asthma
    Rojas Crespo, A.
    Lopez Onieva, M.
    De La Torre Gaspar, Vazquez M.
    Blanca Lopez, N.
    Hernandez Coello, A., I
    Costo Romero, N.
    Rodriguez Alcantara, M., V
    Ramos Vital, C.
    Rodriguez Martinez, M. A.
    Canto Diez, G.
    ALLERGY, 2018, 73 : 826 - 826
  • [45] Reduction in asthma exacerbation rate after mepolizumab treatment initiation in patients with severe asthma: A real-world database study in Japan
    Nagase, Hiroyuki
    Tamaoki, Jun
    Suzuki, Takeo
    Nezu, Yasuko
    Akiyama, Shoko
    Cole, Ashley L.
    Yang, Shibing
    Mu, George
    Katsumata, Masayuki
    Komatsubara, Masaki
    Alfonso-Cristancho, Rafael
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2022, 75
  • [46] Omalizumab therapy for asthma patients with poor adherence to inhaled corticosteroid therapy
    Hendeles, Leslie
    Khan, Yasmeen R.
    Shuster, Jonathan J.
    Chesrown, Sarah E.
    Abu-Hasan, Mutasim
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2015, 114 (01) : 58 - U128
  • [47] INHALED STEROID MAINTENANCE TREATMENT OF SEVERE ASTHMA
    BLACK, P
    LANCET, 1993, 341 (8842): : 445 - 446
  • [48] Proportion of Severe Asthma Patients Eligible for Mepolizumab Therapy by Age and Age of Onset of Asthma
    Comberiati, Pasquale
    McCormack, Katherine
    Malka-Rais, Jonathan
    Spahn, Joseph D.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2019, 7 (08): : 2689 - +
  • [49] A REVIEW OF SEVERE ASTHMA PATIENTS' ADHERENCE TO PREVENTER INHALERS AFTER 12 MONTHS OF MEPOLIZUMAB
    Elsey, L.
    Holmes, L. J.
    Johnson, K.
    Niven, R.
    THORAX, 2019, 74 : A139 - A140
  • [50] Characterisation of severe eosinophilic asthma patients who failed Mepolizumab therapy
    Elneima, Omer
    Ibrahim, Wadah
    Boddy, Claire
    Murphy, Anna
    Bradding, Peter
    Brightling, Christopher
    Siddiqui, Salman
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
12345